Physician profile
Mark Gregory Jones
NPI 1215165303
$3,865.90
in general payments reported to CMS, 2019-2025
12 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,487 · 2021: $44.81 · 2023: $1,135 · 2024: $74.32 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677 · Travel and Lodging: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.50 |
| Travel and Lodging | $657.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,391.64 | 2019 | |
| Stryker Corporation | $884.97 | 2019-2023 | 1688, Spy-Phi System |
| Depuy Synthes Sales INC. | $266.68 | 2023 | |
| Vantive US Healthcare LLC | $72.97 | 2025 | Renal - Pd |
| Kerecis Limited | $56.29 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Biom'Up France Sas | $44.81 | 2021 | |
| Tela Bio, INC. | $33.37 | 2024 | Ovitex 2s |
| Shire North American Group INC | $30.48 | 2019 | |
| Boston Scientific Corporation | $25.23 | 2024 | Spyglass Discover |
| Baxter Healthcare | $24.02 | 2025 | Perclot |
| Medtronic, INC. | $19.72 | 2023 | Argyle |
| Mozarc Medical US LLC | $15.72 | 2024 | Chameleon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.